Phase 3 MagnetisMM-5 trial data in multiple myeloma highlight progression-free survival gains and key safety considerations ...
The landscape of oncology nursing has undergone a seismic shift in safety protocols over the last two decades. In the latest ...
Paget disease of the breast: key signs, diagnosis, and treatment strategies oncology nurses should know to support early ...
Oncology nurse practitioners discuss CD38-based frontline therapy for newly diagnosed multiple myeloma, including Dara-VRd ...
Dr. Azmi emphasized that oncology nurses are often on the front lines of patient education and can play a critical role in ...
FDA accepts Zanidatamab combo sBLA for HER2+ gastroesophageal cancer, showing improved outcomes in HERIZON-GEA-01 trial with ...
FDA expands Alpha DaRT IMPACT trial to 40 patients, adding gemcitabine and nab-paclitaxel cohort in pancreatic cancer.
When we think about cancer and treatment, we often picture older patients who have lived many years and now face a new ...
FDA grants fast track designation to lunresertib plus zedoresertib for genomic-defined platinum-resistant ovarian cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results